Lucy C Chappell, Peter Brocklehurst, Marcus Green, Pollyanna Hardy, Rachael Hunter, Alice Beardmore-Gray, Ursula Bowler, Anna Brockbank, Virginia Chiocchia, Alice Cox, Kate Duhig, Jessica Fleminger, Carolyn Gill, Melanie Greenland, Eleanor Hendy, Ann Kennedy, Paul Leeson, Louise Linsell, Fergus P McCarthy, Jamie O'Driscoll, Anna Placzek, Lucilla Poston, Stephen Robson, Pauline Rushby, Jane Sandall, Laura Scholtz, Paul T Seed, Jenie Sparkes, Kayleigh Stanbury, Sue Tohill, Basky Thilaganathan, John Townend, Edmund Juszczak, Neil Marlow, Andrew Shennan
BACKGROUND: In women with late preterm pre-eclampsia (i.e. at 34+0 to 36+6 weeks' gestation), the optimal delivery time is unclear because limitation of maternal-fetal disease progression needs to be balanced against infant complications. The aim of this trial was to determine whether or not planned earlier initiation of delivery reduces maternal adverse outcomes without substantial worsening of perinatal or infant outcomes, compared with expectant management, in women with late preterm pre-eclampsia...
November 30, 2022: Health Technology Assessment: HTA